Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth C Anderson

Showing results (131-140 of 868) with videos related to

Pageof 87
Sort By:
Blood Cancer Journal|August 14, 2019
Blockade of ubiquitin receptor Rpn13 in plasmacytoid dendritic cells triggers anti-myeloma immunityArghya Ray, Yan Song, Dharminder Chauhan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2022
Microenvironment Is a Key Determinant of Immune Checkpoint Inhibitor ResponseShih-Feng Cho, Kenneth C Anderson, Yu-Tzu Tai
Oncogene|June 12, 2024
Editorial Expression of Concern: Biologic sequelae of interleukin-6 induced PI3-K/Akt signaling in multiple myelomaTeru Hideshima, Noriaki Nakamura, Dharminder Chauhan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 13, 2005
Identification and validation of novel therapeutic targets for multiple myelomaTeru Hideshima, Dharminder Chauhan, Paul Richardson, et al.
Medical Oncology (Northwood, London, England)|February 20, 2010
The evolution and impact of therapy in multiple myelomaJacob P Laubach, Paul G Richardson, Kenneth C Anderson
Hematology/Oncology Clinics of North America|November 13, 2007
Mouse models of human myelomaConstantine S Mitsiades, Kenneth C Anderson, Daniel R Carrasco
Annals of Translational Medicine|February 12, 2019
BCMA CAR T-cell therapy arrives for multiple myeloma: a realityShih-Feng Cho, Kenneth C Anderson, Yu-Tzu Tai
Frontiers in Immunology|August 28, 2018
Targeting B Cell Maturation Antigen (BCMA) in Multiple Myeloma: Potential Uses of BCMA-Based ImmunotherapyShih-Feng Cho, Kenneth C Anderson, Yu-Tzu Tai
Expert Opinion on Therapeutic Targets|June 7, 2005
Targeting signalling pathways for the treatment of multiple myelomaKlaus Podar, Teru Hideshima, Dharminder Chauhan, et al.
Blood Reviews|August 7, 2002
Novel therapies for multiple myelomaJoan J Ryoo, Craig Emmitt Cole, Kenneth C Anderson
Pageof 87

Showing results (131-140 of 868) with videos related to

Sort By:
Pageof 87
Blood Cancer Journal|August 14, 2019
Blockade of ubiquitin receptor Rpn13 in plasmacytoid dendritic cells triggers anti-myeloma immunityArghya Ray, Yan Song, Dharminder Chauhan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2022
Microenvironment Is a Key Determinant of Immune Checkpoint Inhibitor ResponseShih-Feng Cho, Kenneth C Anderson, Yu-Tzu Tai
Oncogene|June 12, 2024
Editorial Expression of Concern: Biologic sequelae of interleukin-6 induced PI3-K/Akt signaling in multiple myelomaTeru Hideshima, Noriaki Nakamura, Dharminder Chauhan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 13, 2005
Identification and validation of novel therapeutic targets for multiple myelomaTeru Hideshima, Dharminder Chauhan, Paul Richardson, et al.
Medical Oncology (Northwood, London, England)|February 20, 2010
The evolution and impact of therapy in multiple myelomaJacob P Laubach, Paul G Richardson, Kenneth C Anderson
Hematology/Oncology Clinics of North America|November 13, 2007
Mouse models of human myelomaConstantine S Mitsiades, Kenneth C Anderson, Daniel R Carrasco
Annals of Translational Medicine|February 12, 2019
BCMA CAR T-cell therapy arrives for multiple myeloma: a realityShih-Feng Cho, Kenneth C Anderson, Yu-Tzu Tai
Frontiers in Immunology|August 28, 2018
Targeting B Cell Maturation Antigen (BCMA) in Multiple Myeloma: Potential Uses of BCMA-Based ImmunotherapyShih-Feng Cho, Kenneth C Anderson, Yu-Tzu Tai
Expert Opinion on Therapeutic Targets|June 7, 2005
Targeting signalling pathways for the treatment of multiple myelomaKlaus Podar, Teru Hideshima, Dharminder Chauhan, et al.
Blood Reviews|August 7, 2002
Novel therapies for multiple myelomaJoan J Ryoo, Craig Emmitt Cole, Kenneth C Anderson
Pageof 87